Cargando…
Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of action
BACKGROUND: Clozapine has remarkable efficacy on both negative and cognitive symptoms of schizophrenia due to its slight activation of NMDA receptor. In fact, much evidence to the contrary. NMDAR is a complex containing specific binding sites, which are regulated to improve negative symptoms and cog...
Autores principales: | Zhou, Xingqin, Cai, Gangming, Mao, Shishi, Xu, Dong, Xu, Xijie, Zhang, Rongjun, Yao, Zhiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060539/ https://www.ncbi.nlm.nih.gov/pubmed/32143671 http://dx.doi.org/10.1186/s12888-020-02509-z |
Ejemplares similares
-
Preparation of (99m)Tc-PQQ and preliminary biological evaluation for the NMDA receptor
por: Kong, Yanyan, et al.
Publicado: (2010) -
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes
por: Cassoli, Juliana S., et al.
Publicado: (2016) -
Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
por: Bygrave, A M, et al.
Publicado: (2016) -
Olanzapine Reverses MK-801-Induced Cognitive Deficits and Region-Specific Alterations of NMDA Receptor Subunits
por: Liu, Xiao, et al.
Publicado: (2018) -
Cell type-specific pharmacology of NMDA receptors using masked MK801
por: Yang, Yunlei, et al.
Publicado: (2015)